AFP and neoplasm: There were no statistical differences in age, sex, tumor size, etiology of viral infection, Child–Pugh classification, serum AFP, maximal tumor size, number of tumors, liver involvement, extrahepatic metastasis or combined hepatic vein invasion between the subgroup patients with or without additional sorafenib treatment (Table 1).